Home Tag Inflammatory bowel disease (IBD)

Articles in Inflammatory bowel disease (IBD)

Slide item
New approach to JAK inhibitors in the treatment of inflammatory bowel disease
In May 2018, the US Food & Drug Administration approved the use of tofacitinib for the treatment of moderate to severe ulcerative colitis (UC). The drug tofacitinib represents the first Janus kinase (JAK) inhibitor approved in inflammatory bowel disease (IBD). This article will provide a practical approach to the clinical use of tofacitinib, as well as updates on other JAK inhibitors currently in development.
Xem thêm
Cardiology Pediatrics Orthopedics